Iparomlimab and Tuvonralimab Injection in Combination With Lenvatinib or Axitinib for the Treatment of Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma That Has Failed First-Line Systemic Therapy
Clinical trial NCT07277972 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07277972
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-15
- Primary completion
- 2029-11-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.